Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates.
paper
Cited
Public
Unavailable
- Authors
- Lev-Ran, Shaul; Le Foll, Bernard; McKenzie, Kwame; George, Tony P; Rehm, Jürgen
- Year
- 2013
- Journal
- Psychiatry research
- PMID
- 23312479
- DOI
- 10.1016/j.psychres.2012.12.014
This study examines rates of co-morbid mental disorders and indicators of the course of illness among individuals with bipolar disorder and cannabis use disorders (CUD). Data were drawn from the National Epidemiological Survey of Alcohol and Related Conditions (NESARC Wave 1, 2001-2002), a nationally representative sample of adults living in the United States. Among individuals with lifetime prevalence of bipolar disorder (N=1905) rates of CUD in the past 12 months were 7.2%, compared to 1.2% in the general population. Logistic regression models adjusting for sociodemographic variables indicated that individuals with bipolar disorder and co-occurring CUD were at increased risk for nicotine dependence (Adjusted Odds Ratio (AOR)=3.8), alcohol (AOR=6.6) and drug (AOR=11.9) use disorders, as well as antisocial personality disorder (AOR=2.8) compared to those without CUD. Among individuals with co-occurring CUD, age of onset of bipolar disorder was significantly lower and median number of manic, hypomanic and depressive episodes per year was significantly greater compared to individuals without CUD. Co-occurring CUD is associated with significant co-morbidities and a more severe course of illness among individuals with bipolar disorder. Comprehensive evaluation of patients with bipolar disorder should include a systematic assessment of CUD.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The prevalence of cannabis use pre-versus post-cannabis legalization in Canada by mental health status: findings from national repeat cross-sectional surveys. | Rundle S et al. | — | 2026 | → |
| Bipolar Disorder Hospitalizations and Substance Use Disorders: A Nationwide Retrospective Study From 2008 To 2015. | Valente L et al. | — | 2025 | → |
| Comorbid Cannabis Use and Mood Disorders Among Adolescents. | Strong SJ et al. | — | 2025 | → |
| Cannabis use and mood disorders: a systematic review. | Sorkhou M et al. | — | 2024 | → |
| Cariprazine in Bipolar Disorder and Substance Use: A Dual Approach to Treatment? | Pardossi S et al. | — | 2024 | → |
| Changes in Cannabis Use Patterns in Psychiatric Populations Pre- and Post-Legalization of Recreational Cannabis Use in Canada: A Repeated Cross-Sectional Survey. | Sorkhou M et al. | — | 2024 | → |
| Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study. | Das A et al. | — | 2024 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| Association between Cannabis Use Disorder and Mental Health Disorders in the Adolescent Population: A Cohort Study. | Muñoz-Galán R et al. | — | 2023 | → |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. | Tourjman SV et al. | — | 2023 | → |
| Cannabis use and its relationship with bipolar disorder: A systematic review and meta-analysis. | Maggu G et al. | — | 2023 | → |
| Effort-related decision making and cannabis use among college students. | Acuff SF et al. | — | 2023 | → |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | — | 2022 | → |
| Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations. | Winder GS et al. | — | 2022 | → |
| Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status. | Rup J et al. | — | 2022 | → |
| Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes. | Selloni A et al. | — | 2022 | → |
| Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study. | Icick R et al. | — | 2022 | → |
| Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders. | Prisciandaro JJ et al. | — | 2022 | → |
| The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. | Fornaro M et al. | — | 2022 | → |
| Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review. | Carbone EA et al. | — | 2021 | → |
| A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. | Kozak K et al. | — | 2021 | → |
| Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. | Breijyeh Z et al. | — | 2021 | → |
| Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. | Fond G et al. | — | 2021 | → |
| The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review. | Jordan Walter T et al. | — | 2021 | → |
| Alcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study. | Pignon B et al. | — | 2020 | → |
| Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review. | Hasin D et al. | — | 2020 | → |
| Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants. | Rognli EB et al. | — | 2020 | → |
| Heavy cannabis use, dependence and the brain: a clinical perspective. | Kroon E et al. | — | 2020 | → |
| Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. | Bahji A et al. | — | 2020 | → |
| Sex differences in bipolar disorder: Impact of lifetime cannabis use on clinical course, functioning, and quality of life in bipolar disorder. | de la Fuente-Tomás L et al. | — | 2020 | → |
| The Relationship between Cannabis Use and Cognition in People with Bipolar Disorder: A Systematic Scoping Review | Walter TJ et al. | — | 2020 | — |
| Vaping Cannabis Oil: A Case of Catatonia Associated With Use of High-Potency Cannabis. | Manning T et al. | — | 2020 | → |
| Bipolar disorder and the endocannabinoid system. | Arjmand S et al. | — | 2019 | → |
| Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes. | Alhamad T et al. | — | 2019 | → |
| Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis. | Bartoli F et al. | — | 2019 | → |
| Cannabis and Mood Disorders. | Lucatch AM et al. | — | 2018 | → |
| Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study. | Feingold D et al. | — | 2018 | → |
| Genomic variants in an inbred mouse model predict mania-like behaviors. | Saul MC et al. | — | 2018 | → |
| Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado. | Hall KE et al. | — | 2018 | → |
| Alcohol use disorders are associated with increased affective lability in bipolar disorder. | Lagerberg TV et al. | — | 2017 | → |
| Bipolar Disorder and Early Emotional Trauma: A Critical Literature Review on Indicators of Prevalence Rates and Clinical Outcomes. | Dualibe AL et al. | — | 2017 | → |
| Cannabis and development of dual diagnoses: A literature review. | Hanna RC et al. | — | 2017 | → |
| [Cannabis-induced disorders]. | Soyka M et al. | — | 2017 | → |
| Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. | Feingold D et al. | — | 2017 | → |
| Commentary on Ostergaard et al. (2017): Evidence of an association between cannabis use and suicide in subjects with bipolar disorder. | Bartoli F | — | 2017 | → |
| Medical cannabis and mental health: A guided systematic review. | Walsh Z et al. | — | 2017 | → |
| Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders. | Suryadevara U et al. | — | 2017 | → |
| What does quality of life refer to in bipolar disorders research? A systematic review of the construct's definition, usage and measurement. | Morton E et al. | — | 2017 | → |
| An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. | Wilsey B et al. | — | 2016 | → |
| Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder. | Lagerberg TV et al. | — | 2016 | → |
| Cannabis use in first-treatment bipolar I disorder: relations to clinical characteristics. | Kvitland LR et al. | — | 2016 | → |
| Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis. | Hunt GE et al. | — | 2016 | → |
| Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder. | Weinstock LM et al. | — | 2016 | → |
| Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? | Zorrilla I et al. | — | 2015 | → |
| Cannabis and psychopathology: The meandering journey of the last decade. | Ghosh A et al. | — | 2015 | → |
| Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder. | Kvitland LR et al. | — | 2015 | → |
| Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder. | Kim SW et al. | — | 2015 | → |
| Interaction between SLC6A4 promoter variants and childhood trauma on the age at onset of bipolar disorders. | Etain B et al. | — | 2015 | → |
| Longitudinal trajectories of marijuana use from adolescence to young adulthood. | Passarotti AM et al. | — | 2015 | → |
| Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update. | Muneer A | — | 2015 | → |
| Risks associated with the non-medicinal use of cannabis. | Hoch E et al. | — | 2015 | → |
| The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. | Hasin DS et al. | — | 2015 | → |
| The relationship between bipolar disorder and cannabis use in daily life: an experience sampling study. | Tyler E et al. | — | 2015 | → |
| The Use of Cannabis as a Predictor of Early Onset of Bipolar Disorder and Suicide Attempts. | Leite RT et al. | — | 2015 | → |
| What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? | Hall W | — | 2015 | → |
| Allostasis as a conceptual framework linking bipolar disorder and addiction. | Pettorruso M et al. | — | 2014 | → |
| Cannabis use and first manic episode. | Bally N et al. | — | 2014 | → |
| Functional impairment in adolescents and young adults with emerging mood disorders. | Scott J et al. | — | 2014 | → |
| Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorder. | Lagerberg TV et al. | — | 2014 | → |
| The adverse health effects of chronic cannabis use. | Hall W et al. | — | 2014 | → |
| Sexually dimorphic, developmental, and chronobiological behavioral profiles of a mouse mania model. | Saul MC et al. | — | 2013 | → |